0001171843-17-005276.txt : 20170828
0001171843-17-005276.hdr.sgml : 20170828
20170828205400
ACCESSION NUMBER: 0001171843-17-005276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170824
FILED AS OF DATE: 20170828
DATE AS OF CHANGE: 20170828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDENBERG CYNTHIA L
CENTRAL INDEX KEY: 0001202016
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 171055934
MAIL ADDRESS:
STREET 1: C/O XIMMUNOMEDICS INC
STREET 2: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN CYNTHIA L
DATE OF NAME CHANGE: 20021029
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
4
1
formfour.xml
FORM 4
X0306
4
2017-08-24
0
0000722830
IMMUNOMEDICS INC
IMMU
0001202016
GOLDENBERG CYNTHIA L
C/O IMMUNOMEDICS, INC.
300 THE AMERICAN ROAD
MORRIS PLAINS
NJ
07950
1
0
0
0
Common Stock
2017-08-24
4
S
0
25000
10.2442
D
813219
D
Common Stock
2017-08-28
4
S
0
5000
11.45
D
808219
D
Common Stock
2017-08-28
4
S
0
10000
11.5591
D
798219
D
Common Stock
5128014
I
See Footnote
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $10.15 to $10.31.
The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
Includes a total of 635,935 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, a director of the issuer and the Issuer's Chief Scientific Officer and Chief Patent Officer.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $11.55 to $11.59.
Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
/s/ Cynthia L. Goldenberg
2017-08-28